mani
positivestrand
rna
virus
encod
gene
function
tran
wherea
gene
requir
ci
genom
replic
mechan
underli
transand
cisprefer
fulli
understood
evalu
concept
hepat
c
viru
hcv
import
caus
chronic
liver
diseas
member
flavivirida
famili
hcv
encod
five
nonstructur
ns
gene
requir
rna
replic
date
two
gene
transcompl
lead
suggest
replicas
gene
work
ci
describ
new
quantit
system
measur
cisand
transrequir
hcv
ns
gene
function
rna
replic
identifi
sever
lethal
mutat
gene
complement
tran
alon
combin
express
polyprotein
synthet
mrna
although
rna
bind
polymeras
activ
suppli
tran
protein
express
requir
ci
indic
cisact
role
replicas
assembl
distinct
known
enzymat
activ
furthermor
rna
bind
ntpase
activ
helicas
domain
requir
ci
suggest
activ
play
essenti
role
rna
templat
select
comprehens
complement
group
analysi
reveal
function
linkag
upstream
gene
final
polymeras
activ
segreg
daclatasvirsensit
activ
could
explain
synergi
antivir
compound
nucleosid
analog
patient
togeth
studi
defin
sever
new
aspect
hcv
replicas
structurefunct
help
explain
potenc
hcvspecif
combin
therapi
provid
experiment
framework
studi
cisand
transact
activ
positivestrand
rna
viru
replic
gener
plo
pathogen
rna
virus
encod
one
protein
form
rna
replicas
serv
propag
viral
rna
genom
replic
gene
function
tran
mean
protein
express
one
viral
genom
complement
assist
replic
defect
mutant
viru
within
cell
viral
gene
work
ci
mean
unabl
complement
defect
mutant
cisact
gene
therefor
link
replic
viral
rna
genom
translat
genet
complement
reflect
format
molecular
interact
previous
absent
nonfunct
understand
cisand
transact
viral
replic
protein
provid
insight
structur
function
viral
replicas
develop
novel
methodolog
studi
interact
compon
viral
replicas
defin
essenti
cisand
transact
five
hepat
c
viru
hcv
replic
gene
product
studi
show
repres
defect
hcv
replic
protein
complement
tran
howev
specif
featur
requir
ci
indic
protein
specif
function
replic
genom
encod
data
defin
import
activ
hcv
replic
protein
provid
new
insight
protein
function
togeth
enzym
complex
plo
pathogen
lowfidel
rna
viru
replic
give
rise
swarm
mutant
variant
genet
interact
one
anoth
mutant
virus
may
complement
inhibit
one
anoth
tran
import
consequ
viru
evolut
pathogenesi
emerg
drugresist
instanc
subgenom
ie
less
genom
length
defectiveinterf
di
virus
depend
compet
helper
virus
intact
genom
competit
mani
positivestrand
rna
virus
evolv
genom
qualiti
control
mechan
requir
specif
viral
gene
ci
case
essenti
cisact
rna
sequenc
secondari
structur
embed
within
viral
code
region
case
rna
replic
requir
ribosom
translat
specif
gene
region
although
gene
product
necessarili
requir
ci
final
cisact
viral
protein
recruit
rna
translat
rna
replic
complex
one
group
virus
exhibit
mark
cisprefer
flavivirida
larg
famili
envelop
positivestrand
rna
virus
includ
sever
global
import
human
anim
pathogen
member
famili
genet
divers
share
similar
genom
organ
mechan
gene
express
replic
strategi
model
rna
replic
bestcharacter
member
famili
hepat
c
viru
hcv
human
pathogen
caus
chronic
liver
diseas
cirrhosi
liver
cancer
major
target
antivir
design
hcv
genom
lack
cap
polyadenyl
tail
highli
structur
noncod
region
well
intern
rna
cisrepl
element
cre
within
code
region
fig
rna
structur
import
cisact
sequenc
direct
translat
replic
viral
genom
includ
intern
ribosom
entri
site
ire
initi
capindepend
translat
positivestrand
rna
virus
hcv
genom
translat
directli
produc
polyprotein
cleav
cellular
viral
proteinas
structur
proteinscor
nonstructur
ns
fig
multipl
round
translat
subset
ns
protein
recruit
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
p
student
ttest
genom
translat
membranebound
replic
complex
replicas
contain
multipl
copi
fig
gene
involv
viru
particl
assembl
dispens
rna
replic
contrast
requir
rna
replic
minim
set
hcv
gene
necessari
produc
selfrepl
subgenom
rna
replicon
sgr
rna
replic
thought
occur
via
de
novo
ie
unprim
initi
near
end
templat
genom
product
complementari
neg
strand
iter
use
neg
strand
secondari
templat
make
mani
new
positivestrand
genom
much
known
structur
function
individu
protein
although
molecular
architectur
replicas
yet
known
bifunct
enzym
encod
ntermin
serin
proteas
domain
ctermin
helicas
domain
serin
proteas
requir
interact
optim
activ
respons
cleav
downstream
polyprotein
also
proteolyt
inactiv
specif
cellular
substrat
includ
mav
trif
ctermin
rna
helicas
ntpase
activ
essenti
rna
replic
although
specif
role
activ
unknown
instanc
domain
unwind
doublestrand
rna
dna
vitro
direct
evid
lack
bind
unwind
viral
rna
replic
cycl
vivo
small
protein
bind
act
cofactor
activ
anchor
heterodim
membran
polytop
membran
protein
oligomer
may
serv
scaffold
replicas
assembl
rnabind
phosphoprotein
contain
ntermin
amphipath
membran
anchor
structur
zincbind
domain
direct
homodimer
either
two
altern
conform
larg
nativ
unfold
ctermin
domain
precis
role
rna
replic
yet
clear
known
recruit
cellular
factor
essenti
replicas
assembl
function
includ
cyclophilin
phosphatidylinositol
vesicl
traffick
protein
vapa
viral
rnadepend
rna
polymeras
ctermin
membran
tail
anchor
serin
proteas
polymeras
protein
major
target
hcvspecif
antivir
compound
mutat
hcv
gene
includ
larg
infram
delet
complement
tran
howev
among
gene
requir
rna
replic
shown
transcompl
observ
led
suggest
ns
gene
work
ci
although
underli
basi
ci
requir
remain
unclear
describ
newli
develop
quantit
tool
studi
cisand
transrequir
hcv
rna
replic
identifi
lossoffunct
experi
perform
time
similar
result
e
sgrgluc
replic
sgrneo
cell
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
p
student
ttest
experi
repeat
four
time
similar
result
f
model
express
recod
mrna
mrna
replic
lack
intern
cre
hcv
genom
g
western
blot
antibodi
antibodi
actin
antibodi
lysat
prepar
indic
cell
line
h
sgrgluc
replic
cell
veevgfp
cell
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
p
p
student
ttest
sgrgluc
vs
veevgfp
cell
experi
perform
eight
time
similar
result
hcv
rna
copi
determin
rtqpcr
valu
repres
mean
sd
transfect
perform
triplic
normal
untransfect
control
experi
repeat
three
time
similar
result
dot
line
limit
detect
qrtpcr
assay
p
p
student
ttest
sgrgluc
rna
valu
vs
veevgfp
cell
j
complement
sgrgluc
sensit
dcv
dash
line
comparison
untreat
sgrgluc
sampl
perform
parallel
reproduc
panel
valu
repres
mean
sd
transfect
perform
triplic
normal
untransfect
control
experi
repeat
three
time
similar
result
k
coloni
format
sgrneo
sgrneo
determin
indic
cell
line
crystal
violet
stain
l
complement
sgrgluc
sgrgluc
sgrgluc
cell
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
experi
perform
three
time
similar
result
mutat
complement
tran
wherea
rna
bind
polymeras
activ
could
suppli
tran
express
requir
ci
suggest
structur
role
replicas
assembl
subset
activ
requir
ci
includ
helicas
rna
bind
ntpase
activ
site
residu
implic
helicas
activ
recruit
rna
templat
replic
complement
group
analysi
indic
activ
coordin
wherea
activ
requir
intact
set
upstream
gene
follow
latter
observ
show
segreg
daclatasvirsensit
activ
result
reveal
new
aspect
hcv
replicas
structurefunct
provid
insight
combin
antihcv
therapi
establish
experiment
platform
studi
genet
function
interact
gene
product
positivestrand
rna
virus
hcv
sgr
encod
report
gene
provid
quantit
readout
hcv
rna
replic
monitor
hcv
replic
level
time
use
sgrgluc
fig
hcv
genotyp
strain
sgr
autonom
replic
express
gaussia
princep
luciferas
gluc
earli
time
posttransfect
hepatoma
cell
sgrgluc
rna
transcript
gluc
express
increas
reach
maxim
express
hour
fig
declin
gluc
activ
later
time
correspond
onset
cytopath
effect
caus
replic
contrast
sgrgluc
mutant
replicon
contain
inactiv
point
mutat
mg
coordin
polymeras
activ
site
residu
tabl
express
gluc
earli
time
point
posttransfect
fig
consist
translat
input
rna
follow
rna
turnov
test
whether
replic
defect
sgrgluc
could
transcompl
sgrneo
cell
stabli
harbor
function
sgr
confer
resist
sgrgluc
effici
replic
cell
wherea
sgrgluc
fig
thu
sgrgluc
transcompl
sgrneo
cell
consist
prior
result
indic
suppli
tran
activ
replicon
hypothes
activ
rna
replic
compet
complement
express
replicon
might
unavail
function
tran
test
idea
express
outsid
context
function
hcv
replicon
use
recod
gene
region
contain
silent
mutat
fig
text
rational
recod
hcv
ensur
effici
express
use
prefer
human
codon
minim
rna
secondari
structur
includ
known
potenti
cisact
replic
element
within
code
region
allow
select
amplif
hcv
replicon
vs
synthet
gene
downstream
analysi
eg
rtpcr
recod
region
express
cell
use
noncytopath
sgr
deriv
venezuelan
equin
enceph
viru
veev
member
alphaviru
genu
togavirida
famili
positivestrand
rna
virus
express
vector
chosen
noncytopath
alphaviru
vector
stabli
abundantli
express
foreign
gene
accommod
larg
insert
use
success
transcomplement
studi
member
flavivirida
includ
hcv
stabl
transduct
cell
vector
produc
cell
hcv
polyprotein
express
physiolog
relev
level
properli
process
proteolyt
cleavag
evidenc
pattern
express
fig
express
stabl
mani
week
passag
neg
control
green
fluoresc
protein
gfp
express
irrelev
protein
via
veev
vector
veevgfp
next
investig
whether
sgrgluc
could
transcompl
cell
inde
sgrgluc
replic
express
gluc
cell
veevgfp
cell
although
kinet
gluc
express
slower
less
robust
wildtyp
sgrgluc
fig
agreement
gluc
express
data
sgrgluc
rna
level
maintain
cell
albeit
reduc
level
compar
sgrgluc
rna
fig
contrast
sgrgluc
rna
level
fell
limit
detect
veevgfp
cell
fig
data
demonstr
hcv
mutant
contain
inactiv
mutat
polymeras
activ
site
transcompl
confirm
sgrgluc
replic
cell
transfect
cell
treat
nm
daclatasvir
dcv
potent
inhibitor
hcv
rna
replic
complex
assembl
dcv
inhibit
replic
effect
concentr
ec
pm
cytostat
concentr
cc
treatment
nm
dcv
abolish
replic
sgrgluc
cell
fig
confirm
observ
transcomplement
sgrgluc
requir
hcv
replicas
activ
next
examin
essenti
featur
suppli
tran
expect
complement
sgrgluc
requir
intact
polymeras
activ
site
recod
polyprotein
fig
furthermor
express
alon
either
introduc
initi
met
codon
fusion
ubiquitin
ensur
authent
ntermin
ser
residu
fail
transcompl
sgrgluc
fig
process
confirm
western
blot
fig
consist
effici
cleavag
ntermin
ubi
fusion
cellular
ubiquitin
ctermin
hydrolas
data
indic
express
alon
insuffici
transcompl
defect
polymeras
activ
suggest
may
need
express
part
polyprotein
also
examin
transcomplement
fulllength
hcv
report
viru
contain
mutat
expect
mutant
unabl
replic
veevgfp
sgrneo
cell
replic
cell
fig
howev
dynam
rang
transcomplement
ie
ratio
highest
lowest
gluc
signal
lower
sgrgluc
consist
higher
replic
effici
sgr
vs
fulllength
hcv
genom
result
low
titer
x
tcid
unitsml
infecti
viru
assay
cell
obtain
fulllength
mutant
sinc
focu
character
cisand
transact
ns
gene
rna
replic
sgr
use
studi
superior
dynam
rang
replicationdepend
gluc
express
determin
longterm
stabil
transcomplement
test
abil
sgrneo
replic
transduc
neoexpress
cell
shown
fig
sgrneo
form
coloni
cell
effici
similar
wildtyp
sgrneo
replicon
follow
select
sgrneo
repliconbear
cell
could
maintain
select
indefinit
mutat
gnn
maintain
stabli
sgrneo
repliconbear
cell
seen
direct
sequenc
result
reversetranscrib
pcramplifi
amplicon
fig
clone
pcr
product
sequenc
twenti
independ
clone
although
revers
possibl
observ
experi
thu
stabl
replic
sgrneo
replicon
due
revers
recombin
recod
gene
also
test
transcomplement
mutant
contain
inactiv
mutat
polymeras
rna
bind
groov
sgrgluc
well
third
mutant
sgrgluc
contain
rna
bind
polymeras
activ
site
mutat
tabl
mutant
transcompl
effici
similar
sgrgluc
fig
contrast
prior
result
data
establish
defect
complement
tran
express
outsid
context
activ
replic
sgr
next
examin
whether
effici
complement
could
improv
prevent
express
defect
protein
howev
gene
simpli
delet
contain
rna
structur
element
cre
requir
rna
replic
therefor
insert
stop
codon
downstream
creat
sgrgluc
tabl
fig
mutant
unabl
replic
surprisingli
complement
tran
fig
consid
three
explan
observ
first
prematur
stop
codon
destabil
sgrgluc
rna
howev
sgrgluc
sgrgluc
express
similar
level
residu
gluc
fig
given
nascent
gluc
collect
time
point
materi
method
data
suggest
nonrepl
sgrgluc
sgrgluc
rna
turn
similar
rate
second
rna
replic
requir
ribosom
transit
code
region
observ
code
region
polioviru
third
protein
requir
ci
distinguish
possibl
design
strategi
permit
ribosom
translat
code
region
without
express
use
altern
read
frame
first
design
sgrgluc
mutant
contain
silent
mutat
code
region
remov
stop
codon
read
frame
maintain
cre
structur
maintain
stop
codon
fig
text
thu
mutant
express
wildtyp
polyprotein
use
alter
codon
usag
creat
untransl
open
read
frame
sgrgluc
autonom
effici
replic
although
slightli
delay
kinet
compar
sgrgluc
fig
indic
silent
mutat
minor
effect
rna
replic
introduc
frameshift
codon
sgrgluc
gene
creat
sgrgluc
mutant
predict
express
amino
acid
protein
tabl
text
b
sgrgluc
replic
complement
tran
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
experi
perform
three
time
similar
result
c
sgrgluc
replic
effici
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
ns
p
p
p
student
ttest
experi
perform
three
time
similar
result
sgrgluc
replic
replic
tran
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
experi
perform
three
time
similar
result
e
sgrgluc
sgrgluc
polyprotein
express
properli
cleav
determin
western
blot
monoclon
antibodi
mutant
replic
express
driven
rna
polymeras
system
unknown
structur
instead
amino
acid
protein
text
sgrgluc
mutant
replic
transcompl
fig
one
possibl
explan
protein
nonspecif
interf
hcv
replic
howev
defect
sgrgluc
replic
observ
transgen
express
tran
argu
protein
domin
neg
effect
replic
also
consid
possibl
frameshift
could
caus
defect
process
polyprotein
includ
ntermin
amino
acid
allow
proper
process
junction
consist
sgrgluc
express
normal
level
fig
indic
proper
cleavag
polyprotein
occur
normal
level
express
togeth
data
show
recod
transgen
unabl
transcompl
sgrgluc
mutant
lack
prematur
stop
codon
allow
ribosom
translat
code
region
express
thu
two
mutant
lack
express
sgrgluc
sgrgluc
complement
tran
simplest
interpret
data
rna
replic
requir
protein
translat
ci
sinc
defect
rna
bind
polymeras
activ
transcompl
fig
cisrequir
therefor
independ
known
enzymat
activ
serin
proteas
rna
helicas
activ
requir
ci
given
success
transcompl
examin
whether
defect
hcv
ns
gene
could
transcompl
cell
initi
test
mutant
contain
lethal
inactiv
mutat
serin
proteas
activ
site
residu
tabl
sgrgluc
sgrgluc
neither
proteas
mutant
replic
complement
tran
fig
also
examin
rna
helicas
domain
mutant
sgrgluc
sgrgluc
contain
lossoffunct
mutat
abrog
rna
bind
ntpase
activ
respect
tabl
neither
helicas
domain
mutant
replic
complement
tran
fig
comparison
third
helicas
domain
mutant
sgrgluc
transcompl
level
similar
mutant
tabl
fig
detail
discuss
sgrgluc
lossoffunct
mutant
lack
rna
unwind
activ
retain
helicas
rna
bind
ntpase
activ
although
data
suggest
hcv
replic
requir
enzymat
activ
ci
two
altern
interpret
specif
mutat
destabil
inact
protein
could
requir
ci
disrupt
underli
rna
structur
within
gene
requir
ci
western
blot
analysi
indic
mutat
caus
slight
increas
accumul
mutat
effect
accumul
fig
expect
mutat
abrog
serin
proteas
cleavag
activ
caus
accumul
unprocess
polyprotein
fig
data
show
helicas
mutat
inhibit
protein
accumul
examin
whether
mutat
disrupt
put
underli
rna
structur
requir
replic
replac
larg
portion
fulllength
hcv
genom
correspond
region
recod
cassett
creat
mutant
fig
tabl
mutant
contain
silent
mutat
includ
rna
bind
ntpase
activ
site
codon
mutat
text
expect
recod
gene
also
exhibit
pronounc
differ
predict
rna
secondari
structur
fig
mutant
replic
effici
slight
delay
kinet
fig
therefor
unlik
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
experi
perform
two
time
similar
result
b
helicas
rna
bind
ntpase
activ
site
mutant
sgrgluc
sgrgluc
replic
complement
tran
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
comparison
sgrgluc
sampl
perform
parallel
reproduc
panel
experi
perform
two
time
similar
result
c
rna
helicas
base
stack
mutant
sgrgluc
replic
complement
tran
effici
similar
sgrgluc
comparison
sgrgluc
sampl
perform
parallel
reproduc
panel
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
p
p
student
ttest
compar
match
time
point
sgrgluc
vs
veevgfp
cell
experi
perform
two
time
similar
result
western
blot
confirm
serin
proteas
activ
site
mutant
sgrgluc
undergo
polyprotein
cleavag
rna
helicas
mutant
sgrgluc
sgrgluc
sgrgluc
sgrgluc
exhibit
defect
accumul
mutat
disrupt
import
rna
element
gene
region
given
inactiv
helicas
mutat
inhibit
protein
accumul
disrupt
import
rna
secondari
structur
conclud
hcv
rna
replic
requir
rna
bind
ntpase
activ
rna
helicas
domain
ci
serin
proteas
activ
requir
ci
need
polyprotein
process
fig
rna
bind
ntpase
activ
helicas
domain
like
need
posttransl
step
replic
rna
templat
recruit
fig
also
examin
transcomplement
addit
mutant
sgrgluc
mutant
contain
lossoffunct
threecodon
delet
linker
region
replic
high
level
cell
fig
indic
transcompl
mutant
also
complement
sgrneo
cell
fig
indic
unlik
complement
activ
replic
replicon
similarli
sgrgluc
mutant
contain
lethal
codon
substitut
acid
domain
replic
cell
fig
sgrneo
cell
fig
effici
transcomplement
also
observ
mutant
sgrgluc
sgr
contain
lethal
mutat
linker
transmembran
domain
respect
tabl
fig
togeth
data
confirm
complement
tran
either
express
recod
region
activ
replic
sgr
prior
work
shown
suppli
tran
consist
result
sgrgluc
sgrgluc
tabl
examin
whether
multipl
defect
could
complement
simultan
combin
two
three
five
inactiv
mutat
within
sgrgluc
replicon
tabl
combin
mutant
replic
cell
veev
gfp
cell
fig
effici
complement
invers
correl
number
mutat
nevertheless
replic
level
statist
signific
sensit
dcv
treatment
confirm
signal
due
activ
hcv
replic
none
combin
mutant
replic
sgrneo
cell
fig
examin
longterm
transcomplement
mutant
contain
multipl
defect
use
select
mutant
sgrneo
replicon
shown
fig
sgrneo
stabli
replic
form
coloni
cell
veevgfp
cell
rtpcr
sequenc
analysi
twelv
independ
cdna
clone
confirm
mutat
retain
detect
use
monoclon
antibodi
valu
repres
rel
level
compar
sgrgluc
mutant
replic
express
driven
rna
polymeras
system
e
design
mutant
f
replic
effici
valu
repres
mean
sd
transfect
done
triplic
normal
untransfect
control
ns
p
p
student
ttest
experi
perform
two
time
similar
result
g
model
show
sgrgluc
sgrgluc
undergo
proteolyt
process
produc
misfold
inact
polyprotein
complement
tran
grey
signifi
nonfunct
serin
proteas
domain
blue
signifi
recod
polyprotein
h
model
show
sgrgluc
sgrgluc
transcompl
may
defect
rna
recruit
compar
fig
grey
signifi
nonfunct
helicas
domain
blue
signifi
recod
polyprotein
cell
popul
data
demonstr
hcv
replicon
combin
defect
five
ns
gene
requir
rna
replic
complement
tran
fig
abil
complement
defect
gene
enabl
us
examin
function
interact
ns
gene
complement
group
analysi
fig
first
creat
cell
line
contain
mutat
within
recod
transgen
wildtyp
sgrgluc
replic
similarli
cell
line
fig
indic
mutant
transgen
domin
neg
effect
hcv
replic
panel
sgrgluc
mutant
test
complement
cell
line
expect
sgrgluc
mutant
fail
replic
cell
express
transgen
contain
defect
gene
fig
thu
defin
distinct
complement
group
nonetheless
effici
transcomplement
vari
among
mutant
gene
suggest
function
interact
exist
correspond
gene
product
notabl
mutant
replic
less
effici
cell
cell
fig
mutant
replic
less
effici
cell
cell
fig
mutant
replic
less
effici
cell
cell
fig
data
indic
activ
enhanc
coexpress
gene
polyprotein
fig
howev
notabl
effect
sgrgluc
fail
replic
fig
data
indic
transcompl
activ
depend
upstream
activ
within
polyprotein
fig
consist
observ
mutant
transcompl
express
alon
fig
contrast
effici
replic
sgrgluc
sgrgluc
sgrgluc
sgrgluc
cell
last
column
fig
indic
activ
ci
depend
upstream
activ
fig
transcomplement
impact
emerg
drugresist
given
transcomplement
link
function
upstream
gene
hypothes
activ
would
segreg
sensit
hcvspecif
direct
act
antivir
compound
target
upstream
gene
product
explor
hypothesi
examin
complement
lethal
mutat
combin
dcv
r
point
tabl
shift
ec
dcv
render
hcv
resist
dcv
expect
replic
sgrgluc
dcv
r
mutant
resist
dcv
fig
dcv
r
mutat
introduc
sgrgluc
replic
resist
dcv
show
kinet
lag
fig
confirm
suppli
tran
surprisingli
transcomplement
sgrgluc
dcv
r
doubl
mutant
sensit
dcv
fig
howev
transcomplement
sgrgluc
resist
dcv
dcv
r
mutat
introduc
fig
data
show
particular
dcvsensit
function
function
tran
independ
howev
transcomplement
activ
segreg
activ
sensit
dcv
confirm
link
function
upstream
activ
within
polyprotein
studi
defin
essenti
cisand
transrepl
activ
five
hcv
replicas
gene
previou
studi
show
defect
hcv
complement
tran
wherea
defect
lead
suggest
function
ci
contrast
found
specif
genet
defect
hcv
complement
tran
yet
activ
requir
ci
viral
gene
gene
product
work
ci
simplest
case
viral
code
region
contain
import
rna
sequenc
secondari
structur
cre
present
within
polioviru
gene
hcv
gene
case
process
rna
translat
requir
although
protein
product
may
irrelev
orf
encod
di
mous
hepat
viru
previous
note
novak
kirkegaard
cistransl
requir
explain
ribosomeinduc
structur
chang
within
rna
templat
fig
recruit
ribosomeassoci
factor
templat
final
cisact
viral
protein
recruit
rna
translat
replic
complex
instanc
nascent
ntermin
polypeptid
bovin
coronaviru
target
rna
templat
site
replic
similar
mechan
observ
brome
mosaic
viru
protein
case
nascent
polypeptid
link
physic
rna
activ
translat
ribosom
fig
altern
cisact
protein
complet
synthesi
may
bind
preferenti
rna
templat
fig
due
spatial
limit
physic
barrier
protein
diffus
tempor
restrict
rapid
protein
turnov
similar
mechan
put
forth
explain
cisact
protein
encod
dna
virus
mobil
genet
element
ci
tran
activ
express
hcv
replicon
exhibit
mark
cisprefer
unabl
transcompl
replicon
defect
data
agre
prior
studi
use
replicon
sourc
howev
could
function
tran
express
part
synthet
polyprotein
envis
two
nonexclus
mechan
could
occur
within
replic
complex
intermingl
ns
protein
exchang
fig
andor
transfer
templat
rna
fig
favor
rna
transfer
model
sgrgluc
complement
express
alon
fig
complement
polyprotein
contain
defect
fig
thu
transcomplement
may
util
rna
transfer
molecular
level
could
reflect
propens
remain
associ
ns
protein
translat
nevertheless
protein
exchang
like
occur
complement
viral
protein
instanc
activ
segreg
promiscu
independ
ns
protein
activ
replicon
express
enzymat
inact
complement
tran
replicon
lack
express
exclud
nonspecif
effect
caus
prematur
stop
codon
potenti
requir
ribosom
transit
code
region
data
indic
cisact
role
replicas
assembl
independ
rna
bind
polymeras
activ
recent
work
shown
rna
polymeras
polioviru
play
import
nonenzymat
role
rna
replic
assembl
twodimension
membranebound
oligomer
lattic
enhanc
rna
bind
synthesi
cooper
intriguingli
hcv
also
form
oligom
show
cooper
rna
synthesi
rate
togeth
data
lend
support
conserv
structur
role
viral
polymeras
positivestrand
rna
viru
replicas
assembl
complement
hcv
tran
occur
express
intact
polyprotein
analog
transcomplement
polymeras
relat
west
nile
viru
subtyp
kunjin
genu
flaviviru
also
requir
coexpress
upstream
ns
protein
suggest
may
common
within
flavivirida
found
hcv
function
link
specif
dcvsensit
function
translat
polyprotein
fridel
colleagu
use
sgr
transcomplement
defin
three
complement
group
show
dcvsensit
function
work
preferenti
ci
contrast
found
dcv
r
allel
function
tran
express
synthet
mrna
thu
cisprefer
overcom
express
outsid
context
function
replicon
complement
also
requir
express
intact
polyprotein
activ
replicon
similar
result
observ
complement
bovin
viral
diarrhea
relat
member
flavivirida
observ
may
relat
influenc
upstream
protein
phosphoryl
statu
interactom
thu
appear
multipl
layer
cislinkag
wherebi
activ
depend
upstream
activ
studi
turn
link
activ
network
linkag
could
serv
qualiti
control
mechan
reduc
emerg
di
genom
despit
abil
function
tran
regard
delet
region
observ
natur
occur
hcv
delet
mutant
given
target
hcvspecif
antivir
find
may
implic
emerg
drug
resist
predict
inhibitor
like
dcv
may
synergist
effect
combin
inhibitor
viral
polymeras
furthermor
barrier
resist
drug
target
may
high
replicaseexpress
complement
tran
link
daclatasvirsensit
activ
upstream
thu
resist
allel
would
need
aris
within
genom
notabl
dcv
sofosbuvir
combin
therapi
show
high
rate
sustain
virolog
respons
hcvinfect
patient
ci
tran
activ
defect
essenti
serin
proteas
rna
bind
ntpase
activ
site
transcompl
phenotyp
unexpect
serin
proteas
mutant
express
uncleav
inact
polyprotein
fig
data
suggest
proteas
inhibitorsensit
viru
would
transcompl
inhibitorresist
viru
vivo
defect
rna
bind
ntpase
activ
also
complement
tran
exclud
nonspecif
effect
caus
instabl
mutant
protein
disrupt
underli
cisact
rna
structur
within
region
viral
genom
data
consist
requir
hcv
rna
bind
ntpase
activ
ci
similarli
flavivirida
ntpase
activ
site
residu
requir
ci
wherea
west
nile
viru
helicas
mutant
transcompl
low
effici
surprisingli
mutant
contain
lethal
mutat
helicas
bookend
residu
complement
tran
residu
key
role
rna
unwind
structur
stack
base
rna
dna
templat
strand
may
keep
templat
regist
three
singlenucleotid
transloc
step
vitro
protein
contain
mutat
retain
rna
bind
ntpase
activ
mutant
defect
rna
unwind
unwind
dna
thu
mutant
sgrgluc
basal
helicas
activ
like
defect
process
rna
templat
establish
hcv
helicas
activ
requir
rna
replic
function
helicas
unclear
includ
whether
bind
unwind
viral
rna
replic
given
posttransl
cisprefer
reli
proteinrna
interact
fig
data
suggest
rna
bind
ntpase
activ
rna
unwind
activ
contribut
rna
templat
recruit
fig
remark
rna
helicasentpas
brome
mosaic
viru
also
recruit
viral
rna
membranebound
replic
complex
thu
rna
templat
recruit
may
conserv
function
positivestrand
rna
virusencod
helicas
defect
linker
domain
ctermin
acid
domain
also
complement
recod
replicon
linker
domain
conserv
essenti
rna
replic
coordin
interact
proteas
helicas
domain
may
mediat
proteinprotein
interact
via
put
motif
acid
domain
contribut
helicas
activ
promot
rnacoupl
atp
hydrolysi
affect
interact
downstream
protein
helicas
activ
recombin
protein
contain
mutat
effici
basal
rnabind
activ
sever
reduc
atpcoupl
rna
bind
rnastimul
atpas
activ
rna
unwind
thu
mutant
independ
confirm
rna
unwind
activ
helicas
suppli
tran
base
abil
complement
repres
defect
conduct
detail
complement
group
analysi
hcv
gene
experi
reveal
function
interact
replicon
transcompl
less
effici
cell
express
form
wherea
replicon
transcompl
less
effici
cell
express
form
one
interpret
data
preferenti
interact
polyprotein
fig
given
complement
group
reciproc
surpris
replicon
replic
well
cell
express
form
furthermor
surpris
activ
segreg
independ
given
proteolyt
process
junction
autocatalyt
predict
lead
cispreferenti
interact
one
possibl
explan
dimer
one
monom
provid
activ
provid
activ
fig
inde
recent
demonstr
transmembran
domain
mediat
homodimer
essenti
rna
replic
altern
second
explan
might
heterodim
exchang
partner
form
singl
fulli
activ
heterodim
fig
abl
complement
hcv
sgr
contain
lossoffunct
mutat
everi
replic
gene
fig
notabl
hcv
minigenom
system
develop
hcv
minigenom
rna
encod
report
gene
flank
hcv
noncod
region
lack
ns
protein
express
minigenom
presum
replic
tran
hcv
replicon
transgen
express
given
cisrequir
describ
surpris
minigenom
replic
tran
howev
minigenom
replic
level
compar
directli
replicon
infecti
viru
replic
level
sensit
hcvspecif
antivir
compound
demonstr
key
featur
system
minigenom
rna
produc
continu
transcript
transfect
cdna
henc
may
repres
singl
round
rna
synthesi
rather
bona
fide
rna
replic
amplif
regard
capabl
nonspecif
rna
synthesi
absenc
hcv
ns
protein
overexpress
cell
cultur
contrast
transrepl
system
describ
support
authent
longterm
replic
defect
hcv
replicon
initi
rna
transfect
summari
identifi
sever
cisand
transact
activ
hcv
gene
essenti
rna
replic
includ
nonenzymat
cisact
role
replicas
assembl
rna
bind
ntpase
activ
like
involv
templat
recruit
activ
cosegreg
complement
group
analysi
wherea
activ
depend
function
upstream
gene
togeth
studi
reveal
network
function
interact
could
serv
qualiti
control
mechan
hcv
replicas
gene
exploit
combin
therapi
target
multipl
ns
protein
activ
materi
method
cdna
construct
rna
transcript
sgrgluc
previous
describ
pysgrjfhgluc
noncytopath
veev
vector
kind
gift
dr
ilya
frolov
univers
alabama
birmingham
modifi
replac
gfp
insert
short
multiclon
site
briefli
oligo
tabl
anneal
ligat
xbaibsrgi
site
yield
pveevmc
region
recod
geneart
regensburg
germani
optim
human
codon
usag
minim
rna
structur
remov
repeat
sequenc
rna
instabl
motif
atrich
gcrich
sequenc
text
recod
region
subclon
fragment
pveevmc
cut
paci
pmei
creat
subclon
speibsteii
fragment
recod
make
psgrgluc
recod
end
text
synthes
blue
heron
biotech
bothel
wa
clone
psgrgluc
bsrgi
xbai
fragment
psgrgluc
construct
cleav
psgrgluc
bsrgi
fillin
dntp
klenow
enzym
follow
relig
construct
subclon
speibsteii
fragment
recod
region
mutat
introduc
sgrgluc
sitedirect
mutagenesi
appropri
primer
pair
tabl
sgrgluc
describ
previous
pysgrjfhgluc
gnn
sgrgluc
construct
subclon
mutat
recod
gene
creat
via
pcr
use
primer
recod
gene
construct
overlap
extens
pcr
primer
larg
high
copi
number
plasmid
clone
effici
improv
use
high
capac
e
coli
strain
agil
contrast
unabl
obtain
veev
vector
express
unrecod
cassett
test
whether
recod
process
enabl
transcomplement
despit
numer
clone
attempt
sever
bacteri
host
strain
given
recod
cassett
success
subclon
veev
vector
sever
time
suspect
authent
sequenc
advers
impact
stabil
pveev
plasmid
nevertheless
recod
region
function
tran
use
studi
construct
confirm
restrict
digest
andor
sanger
sequenc
sequenc
dna
segment
amplifi
vitro
confirm
subclon
hcv
rna
veev
transcript
produc
previous
describ
rna
transcript
treat
dnase
ambion
purifi
qiagen
rneasi
kit
oncolumn
dnase
digest
rna
concentr
check
spectrophotometri
adjust
rna
integr
check
agaros
gel
electrophoresi
aliquot
store
human
hepatoma
cell
maintain
complet
growth
medium
dulbecco
modifi
eagl
medium
dmem
invitrogen
contain
heatinactiv
fetal
calf
serum
omega
scientif
mm
nonessenti
amino
acid
invitrogen
cell
transfect
veev
rna
electropor
describ
two
day
electropor
transfect
cell
select
complet
growth
medium
contain
puromycin
invivogen
passag
time
frozen
thaw
cell
maintain
puromycincontain
complet
growth
medium
use
within
passag
cell
seed
experi
complet
growth
medium
lack
puromycin
cell
transfect
hcv
replicon
use
rna
transit
mrna
transfect
reagent
miru
accord
manufactur
instruct
dcv
kind
gift
mingjun
huang
achillion
pharmaceut
select
stabl
repliconbear
cell
cell
transfect
cm
dish
two
day
posttransfect
medium
chang
complet
growth
medium
contain
mgml
invitrogen
select
week
triweekli
media
chang
coloni
fix
methanol
stain
crystal
violet
time
point
media
collect
cell
wash
three
time
phosphat
buffer
salin
fresh
media
ad
collect
media
clarifi
centrifug
min
x
g
place
fresh
tube
mix
volum
lysi
buffer
promega
neb
store
frozen
sampl
assay
gluc
activ
berthold
centro
lb
plate
reader
berthold
centro
xs
lb
cell
lysat
prepar
equal
amount
protein
electrophores
sdspage
transfer
polyvinyliden
difluorid
membran
immunoblot
monoclon
antibodi
virogen
studi
monoclon
antibodi
monoclon
antibodi
biofront
monoclon
antibodi
sigma
antibodi
notic
antibodi
larg
lottolot
variabl
reactiv
nonspecif
background
protein
mass
estim
base
migrat
supersign
enhanc
molecular
weight
protein
ladder
pierc
rockford
il
analyz
polyprotein
express
defect
replicon
rna
polymeras
express
system
use
briefli
cell
seed
x
well
sixwel
plate
day
use
cell
infect
h
multipl
infect
moi
transfect
psgrgluc
deriv
use
miru
reagent
accord
manufactur
recommend
lysat
collect
h
posttransfect
rel
express
fig
quantit
use
gel
analyz
densitometri
featur
nih
imagej
recombin
hcv
protein
express
purifi
e
coli
describ
balbc
mice
prime
boost
interv
recombin
protein
complex
adjuv
ribi
immunochem
approxim
month
last
boost
sera
harvest
test
immunoreact
hcvinfect
cell
mice
high
titer
specif
signal
dilut
boost
intraven
purifi
protein
pb
splenocyt
harvest
later
fuse
myeloma
cell
gener
hybridoma
accord
publish
procedur
total
hybridoma
deriv
repeat
subclon
monoclon
antibodi
purifi
standard
protein
aprotein
g
chromatographi
monoclon
antibodi
found
react
protein
western
blot
hcvinfect
cell
vs
uninfect
control
cell
monoclon
antibodi
develop
fusion
describ
elsewher
rna
harvest
use
trizol
reagent
invitrogen
sequenc
analysi
hcv
rna
amplifi
select
cell
popul
rtpcr
amplicon
directli
submit
sanger
sequenc
pcr
product
also
clone
invitrogen
multipl
independ
cdna
clone
sequenc
hcv
rna
quantit
qrtpcr
previous
describ
normal
total
rna
concentr
briefli
rna
assay
reaction
contain
nm
hcv
iresspecif
hydrolysi
probe
gag
tgt
cgt
gca
gcc
nm
forward
cac
gca
gaa
agc
gtc
nm
revers
gca
ccc
tat
cag
gca
primer
lightcycl
rna
amplif
kit
roch
reaction
analyz
roch
lightcycl
use
minut
rt
step
minut
denatur
step
follow
cycl
denatur
second
anneal
second
extens
second
quantit
curv
construct
analyz
hcv
rna
standard
parallel
transfect
experi
perform
least
twice
experi
contain
least
three
replic
cell
cultur
independ
plate
transfect
sampl
analyz
mean
rel
light
unit
rlu
valu
calcul
standard
deviat
sd
base
replic
data
plot
match
control
sampl
collect
parallel
mani
sampl
could
process
parallel
posit
neg
control
present
across
multipl
sampl
within
larg
experi
explicitli
note
figur
legend
background
sensit
luciferas
assay
affect
lysi
buffer
luminomet
hardwar
data
normal
untransfect
cell
divid
mean
valu
sampl
mean
valu
match
mocktransfect
cell
collect
parallel
calcul
sd
valu
normal
data
propag
error
account
describ
statist
signific
calcul
graphpad
prism
use
twotail
pair
student
ttest
normal
replic
data
time
point
support
inform
fig
transcomplement
sgrgluc
replic
cell
indic
activ
site
requir
tran
b
sgrgluc
complement
express
alon
via
c
western
blot
confirm
cleav
presum
ubiquitin
ctermin
hydrolas
produc
fulllength
complement
fulllength
hcv
report
viru
cell
valu
repres
mean
sd
transfect
perform
triplic
normal
untransfect
control
experi
repeat
three
time
similar
result
e
sanger
sequenc
transcompl
sgrneo
three
week
select
two
week
addit
passag
total
rna
extract
cell
trizol
reagent
hcvspecif
cdna
synthes
gene
region
amplifi
rtpcr
pcr
product
directli
sequenc
comparison
parallel
sequenc
dna
shown
pdf
